ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
8082.1;5 LSPP-LS
Project title
Development of an RSV vaccine based on recombinant RSV-F expressed in mammalian cells and formulated in influenza virosomes
Project status Finished
 
Start date 01.03.2006
End date 31.08.2009
 
Granted total costs 467'500.00  CHF
Section 20 Förderbereich Life Sciences
Project category Project
Research type Applied research and development
NABS classification Non divisible / inclassable research
 
Research disciplines
100 % T490 Biotechnology
Last modification of the project
27.11.2014